Contact Jackie Buckle to advertise here:


Druglink archive

Nearly 30 years of DrugScope’s magazine, Druglink, dating back to 1986 now available and searchable on the DrugWise website




NSM logo

The National Substance Misuse Conference 2017

This one day conference will be a unique opportunity to receive leading expert knowledge in these 4 key areas: Strategy & Treatment, Prisons, Prevention and Trends. The conference will help to advance the knowledge, implementation and scale up of evidence‐informed Substance Misuse strategies &  programmes.


Early bird rate £99. For more information or to book see the website



SSA logo

PhD SYMPOSIUM: Weds 8 November

Now in its ninth year, the PhD Symposium brings together students studying addiction-related topics to network, present their work in a supportive environment and share ups and downs.


ANNUAL CONFERENCE 2017: Thurs 9 - Fri 10 November

Featuring: Society Lecture by Louisa Degenhardt, ‘Studying substance use among young people’; The Addiction Debate; Workshop – Demystifying qualitative data analysis; and much more

Crowne Plaza, Newcastle upon Tyne, UK

Early-bird places available



Comments / sponsorship

If you have any comments about DS Daily or to find out about sponsorship please contact the Editor: Jackie Buckle




DS Daily, twitter and Facebook are intended purely as current awareness resources. DS Daily does not endorse nor guarantee the accuracy of the information provided by external sources/links, and accepts no responsibility or liability for any consequences arising from the use of such data. See our editorial policy here




We are pleased to present DS Daily in association with

DDN logo


Follow DDN on Facebook

Thank you to our gold sponsors:



Bristol Drugs Project



EDP Drug & Alcohol Services





Studio House



Thank you to our silver sponsors:


Alcohol Research UK




Aspire services



Australian Drug Foundation



Liverpool John Moores University MSc Public Health Addictions

Public Health Institute
Liverpool John Moores University


Matthew Project



Norfolk Recovery Partnership logo



Could you sponsor DS Daily? Your logo will appear here with a link to your website. Please Email
Harry Shapiro

Follow DrugScope on Twitter


Bookmark and Share






Thank you to our Premium sponsors:

CGL logo

Turning Point


Phoenix Futures logo





EMCDDA banner

Could you sponsor DS Daily? Please Email Harry Shapiro to discuss


Reports July

Follow DrugScope on Twitter

Cork Community Action on Alcohol North Side. (2017) Cork local action on alcohol plan 2016 – 2018. Cork: Cork Community Action on Alcohol North Side

Having participated in the National Community Action on Alcohol Pilot Programme in 2015, supported by the Alcohol Forum, the Cork Local & Southern Regional Drug & Alcohol Task Forces developed and launched its first Alcohol Strategy for Cork and Kerry in 2016 | CAN, Ireland

Alcohol treatment in Ireland: HRB publishes latest figures 

Latest alcohol treatment figures from the Health Research Board (HRB) show 56,702 cases were treated for problem alcohol use in Ireland between 2009 and 2015. Treated cases increased from 7,993 in 2009, to 8,876 in 2011, then decreased year-on-year to 7,616 in 2015 | HRB, Ireland

Childhood adversity, substance misuse and young people’s mental health (PDF)

Substance misuse is just one form of risk-taking behaviour, and can be a sign that young people are dealing with adversity, trauma, and/or experimenting with their identities | Addaction and Young Minds, UK

Stimulating and supporting a black and minority ethnic voice on drugs issues (PDF)

CityWide commissioned this paper to explore possible structures and processes through which to engage with, hear the voice of, and empower Black and minority ethnic communities in relation to issues of drug use | CityWide, Ireland

Fentanyl: a brief guide for first responders (PDF)

This document contains recommendations on potential best practices for first responders that may encounter, test and transport exhibits that could contain fentanyl‐related substances.   It also contains recommendations for handling and processing of crime scenes and non‐drug evidence, like money, that could be contaminated | DEA, USA

A performance measurement framework for drug and alcohol task forces

This study is about the development of a Performance Measurement Framework for the Drug and Alcohol Task Forces (DATF). The latter are community-based structures which bring together Government Departments, State Agencies and the Community and Voluntary sectors to provide a collective response to problem substance use | Trutz Haase – Social & Economic Consultants, Ireland

EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl)

In November 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide, commonly known as furanylfentanyl, through a joint assessment | EMCDDA, Portugal

EMCDDA assessment of drug-induced death data and contextual information in selected countries

This report examines the triggers and dynamics of drug-related death in the seven EMCDDA Member States with the highest drug-related death (DRD) rates per population. The report explores whether between-country variations might be explained in part by differences in the number of drug users at risk of DRD, and by differences in the level of DRD risk among those who are at risk | EMCDDA, Portugal

Annual accounts 2016

These are the EMCDDA's final annual accounts for the financial year 2016 | EMCDDA, Portugal

It's Time for the U.S. to Decriminalize Drug Use and Possession

By any measure and every metric, the U.S. war on drugs — a constellation of laws and policies that seeks to prevent the use of certain drugs, primarily through punishment and coercion — has been a catastrophic failure | DPA, USA

Drug Strategy 2017

The drug strategy 2017 (PDF) sets out how the government and its partners, at local, national and international levels, will take new action to tackle drug misuse and the harms it causes | Home Office, UK

Drug strategy 2016: development review

A review of the evidence on the 2016 drug strategy by the Advisory Council on the Misuse of Drugs (ACMD) | ACMD, UK

Updated drug misuse clinical guidelines published

The update to Drug Misuse and Dependence: UK guidelines on clinical management (often called the orange book) has been published. Last updated in 2007, the newly updated guidelines endorse much of the previous guidelines. But there is a stronger emphasis on recovery and on a holistic approach to the issues and interventions that can support recovery. Key additions and reinforced messages for 2017 include: incorporation of clinical guidance on prison-based treatment, new psychoactive substances and club drugs, mental health co-morbidity, misuse of prescribed and over-the-counter medicines, smoking cessation, and preventing drug-related deaths, including naloxone provision | PHE, UK

Psychoactive Substances Bill: evaluation review

An evaluation review of the Psychoactive Substances Bill by the Advisory Council on the Misuse of Drugs (ACMD) | ACMD, UK

New report from Canada’s Drug Futures Forum outlines recommendations for the next decade of drug policy in Canada

Recommendations from a meeting of over 200 policymakers, public health officials, law enforcement professionals, researchers, people who use drugs, and community organizers provides an innovative roadmap to improve Canada’s policy response to illegal drugs over the coming ten years | Canada's Drug Futures Forum, Canada

New UNODC report: Coca crops in Colombia increase over 50 per cent in one year

he latest Colombia Cultivation Survey, produced by the Integrated System for Monitoring Illicit Crops (SIMCI) Project of UNODC, was released today, showing an increase of 52 per cent in coca cultivation area - from 96,000 hectares (ha) in 2015 to 146,000 ha in 2016 | UNODC, USA

Reducing Harm, Supporting Recovery 2017 – 2025

Ireland’s “Reducing Harm, Supporting Recovery” strategy sets out the Government’s response to addressing the harm caused by substance misuse in our society over the next eight years.  It identifies a set of key actions to be delivered between 2017 and 2020, and provides an opportunity for the development of further actions from 2021 to 2024 to address needs that may emerge later on in the lifetime of the strategy | Department of Health, Ireland

The drugs situation in Ireland: an overview of trends from 2005 to 2015 (PDF)

This report presents an overview of trends in the drugs situation in Ireland over a 10 year period. The report analyses the most recent data available with respect to the five European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) key indicators (prevalence of drug use, high risk drug use, treatment demand, drug-related deaths and mortality and drug-related infectious diseases) as well as drug-related crime and supply. Where data is available, trends under these six headings since 2005 are reported. In addition to presentation of national trends this reported includes additional evidence looking at trends in data relating to specific sub-populations including people who inject drugs, prisoners, homeless individuals, sex workers and the Travelling community | PHI, UK

HRB drug and alcohol evidence reviews (PDF)

This review examines the evidence on the effectiveness of interventions in the areas of harm reduction, prevention, treatment and long-term recovery related to illicit drug misuse and dependence | Health Research Board, Ireland

Drug-related intimidation. The Irish situation and international responses: an evidence review (PDF)

Drug-related intimidation is a pervasive and pressing issue negatively impacting the health and well-being of individuals, families, communities and the functioning of local agencies that serve them. The aim of this evidence review is to critically appraise the national and international evidence to identify best practice, community-based responses to DRI to inform: a) DRI action points within the upcoming National Drugs Strategy, 2017–2026, and b) Drugs Task Force action plans for implementing responses to DRI in their local communities | Health Research Board, Ireland

Ireland Thinks poll on attitudes to alcohol consumption Commissioned by Alcohol Action Ireland Conducted June 12th to June 16th 2017 (PDF)

A new opinion poll commissioned by Alcohol Health Alliance Ireland shows strong support for Government action to curb alcohol marketing that appeals to young people | Alcohol Action Ireland, Ireland

Budget 2017

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the Management Board, which may modify the draft before adopting it and submitting it to the European Commission. The Commission, in turn, makes its recommendations (which may again alter the draft) and presents the result to the European Council and Parliament | EMCDDA, Portugal

Albania, National Drug Report 2017

This report is prepared in the framework of the EMCDDA-IPA5 project ‘Further preparation of the IPA beneficiaries for their participation with the European Monitoring Centre for Drugs and Drug Addiction’ funded by the European Commission. It provides a top-level overview of the drug phenomenon in Albania, covering drug supply, use and public health problems as well as drug policy and responses. It has been produced with the financial assistance of the European Union | EMCDDA, Portugal

Serbia, National Drug Report 2017

This report is prepared in the framework of the EMCDDA-IPA5 project ‘Further preparation of the IPA beneficiaries for their participation with the European Monitoring Centre for Drugs and Drug Addiction’ funded by the European Commission. It provides a top-level overview of the drug phenomenon in Serbia, covering drug supply, use and public health problems as well as drug policy and responses. It has been produced with the financial assistance of the European Union | EMCDDA, Portugal

SAMHSA report shows the usage of non-medical pain relievers across the nation

A new report by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that 4.31 percent of people aged 12 or older in the U.S. used prescription pain relievers non-medically in the past year. When taken without a physician's direction, prescription opioid pain relievers can lead to a higher risk of serious adverse consequences such as substance use disorder, overdose, or death | SAMSHA, USA

Towards a smoke-free generation: tobacco control plan for England

Outlining plans to reduce smoking in England, with the aim of creating a smoke-free generation | DoH, UK

Cost of smoking to the NHS in England: 2015

Data on the cost of smoking to the NHS to support the development of the new Tobacco Control Plan for England | PHE, UK

Local alcohol consumption: national survey results

A summary of results from an alcohol consumption survey of 25 upper tier local authorities in England | PHE, UK

Smokefree Skills: An assessment of maternity workforce training

Time and again as this report was developed, stakeholders, midwives, obstetricians and others would agree that the issue of smoking in pregnancy was extremely important. The oft repeated phrase was that this importance “goes without saying”. This, it seems, is the crux of the problem | ASH, UK

Hepatitis C and people who inject drugs: The family experience

Today we are publishing our report “Marks and scars” on the impact of hepatitis C on the families of people who inject drugs | Adfam, UK